MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from pipe
financing
$89,991K
Proceeds from exercise of
common stock options...
$37K
Net cash provided by
financing activities
$82,461K
Canceled cashflow
$7,567K
Net increase
(decrease) in cash, cash...
$20,838K
Canceled cashflow
$61,623K
Issuance costs from pipe
financing
$7,567K
Non-cash consideration
for acquired...
$67,659K
Stock-based compensation
$6,102K
Change in fair value of
sermonix pre-funded...
$4,579K
Prepaid expenses and
other current and...
-$2,439K
Depreciation expense
$972K
Non-cash lease expense
$273K
Maturities of
available-for-sale securities
$21,749K
Net cash used in
operating activities
-$45,729K
Net cash (used in)
provided by investing...
-$15,894K
Canceled cashflow
$82,024K
Canceled cashflow
$21,749K
Net loss
-$105,609K
Purchases of
available-for-sale securities
$37,643K
Accounts payable and
accrued liabilities
-$21,342K
Operating lease liability
-$414K
Amortization of premiums and
accretion of discounts on...
$329K
Other long-term
liabilities
-$59K
Back
Back
Cash Flow
source: myfinsight.com
LeonaBio, Inc. (LONA)
LeonaBio, Inc. (LONA)